News

Latest

Frontiers in Immunology

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

March 18, 2024

More

LymeX

How Serimmune Inc. is applying machine learning to at-home diagnostics

January 26, 2023

neo.life

Serimmune’s at-home tests use machine learning to compare your “epitope repertoire” against known cases, for more accurate diagnoses of everything from COVID-19 to Lyme disease to Epstein-Barr.

January 26, 2023

Serimmune

Serimmune Named a Phase 1 Winner in HHS and the Cohen Foundation’s LymeX Diagnostics Prize

November 4, 2022

medRxiv

Distinguishing features of Long COVID identified through immune profiling

August 8, 2022

Business Wire

Serimmune and Mymee Collaborate on Research Study to Better Define the Role of Antibodies in SARS-CoV-2 Symptoms

September 21, 2021

The Guardian

UK COVID Variant Extremely Unlikely to Evade Vaccines, Scientists Say

January 10, 2021

CDC

Serimmune SARS-CoV-2 Publication Featured in CDC’s COVID-19 Science Update

November 3, 2020

medRxiv

Serimmune Observes Increasing SARS-CoV-2 Seropositivity in a Cohort of 1,500+ Healthy Blood Donors During New York City Outbreak

October 21, 2020

GenomeWeb

Serimmune Shifts Focus to SARS-CoV-2 Test, Vaccine Development

April 20, 2020

Illumina Ventures

Portfolio Company Spotlight: Serimmune

August 19, 2019

GenomeWeb

Serimmune: Noah Nasser, Bill Welch

August 6, 2019

Pacific Coast Business Times

Startup nets $8M to diagnose more efficiently

February 23, 2018

GenomeWeb

Illumina Ventures Raises $230m for First Fund

October 16, 2017

GEN

Antibody Therapeutics Hinder Immune Evasion

September 1, 2017

GenomeWeb

SerImmune to Focus Immune Mapping Technology on Antigen Discovery, Diagnostic Development

June 28, 2017